References
- World Health Organization. Transmission of SARS-CoV-2: implications for infection prevention precautions. https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions. Updated 2020. Accessed November 23, 2020.
- Patrucco F, Albera C, Bellocchia M, et al. SARS-CoV-2 Detection on Bronchoalveolar Lavage: An Italian Multicenter experience. Respiration. 2020;99(11):970–978. doi:10.1159/000511964.
- Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020;323(18):1843–1844. doi:10.1001/jama.2020.3786.
- Wahidi MM, Shojaee S, Lamb CR, et al. The Use of Bronchoscopy During the Coronavirus Disease 2019 Pandemic: CHEST/AABIP Guideline and Expert Panel Report. Chest. 2020;158(3):1268–1281. doi:10.1016/j.chest.2020.04.036.
- Rajajee V, Williamson CA. Use of a Novel Negative-Pressure Tent During Bedside Tracheostomy in COVID-19 Patients. Neurocrit Care. 2020;33(2):597–603. doi:10.1007/s12028-020-01068-1.
- Goto Y, Yamamoto T, Ozaki M. Aerosol shield and tent for health-care workers’ protection during the coronavirus disease 2019 pandemic. Acute Med Surg. 2020;7(1):e550 doi:10.1002/ams2.550.
- Sorbello M, Rosenblatt W, Hofmeyr R, Greif R, Urdaneta F. Aerosol boxes and barrier enclosures for airway management in COVID-19 patients: a scoping review and narrative synthesis. Br J Anaesth. 2020;125(6):880–894. doi:10.1016/j.bja.2020.08.038.
- Aberle DR, Adams AM, Berg CD, National Lung Screening Trial Research Team, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409. doi:10.1056/NEJMoa1102873.
- de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med. 2020;382(6):503–513. doi:10.1056/NEJMoa1911793.
- Pinsky PF, Church TR, Izmirlian G, Kramer BS. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer. 2013;119(22):3976–3983. doi:10.1002/cncr.28326.
- Ho C, Lefresne S, Liberman M, et al. Lung Cancer in Canada. J Thorac Oncol. 2019;14(7):1128–1133. doi:10.1016/j.jtho.2019.02.012.
- BC Cancer. B.C. launches lung cancer screening program - the first in Canada. http://www.bccancer.bc.ca/about/news-stories/news/2020/b-c-launches-lung-cancer-screening-program-%E2%80%93-the-first-in-canada. Updated 2020. Accessed January, 2021.
- Folch EE, Labarca G, Ospina-Delgado D, et al. Sensitivity and Safety of Electromagnetic Navigation Bronchoscopy for Lung Cancer Diagnosis: Systematic Review and Meta-analysis. Chest. 2020;158(4):1753–1769. doi:10.1016/j.chest.2020.05.534.
- Vakil E, Tremblay A. Flying Blind Despite All Our Instruments. Chest. 2020;158(4):1312–1313. doi:10.1016/j.chest.2020.06.059.
- Sagar AS, Sabath BF, Eapen GA, et al. Incidence and Location of Atelectasis Developed During Bronchoscopy Under General Anesthesia: The I-LOCATE Trial. Chest. 2020;158(6):2658–2666. doi:10.1016/j.chest.2020.05.565.
- Aboudara M, Roller L, Rickman O, et al. Improved diagnostic yield for lung nodules with digital tomosynthesis-corrected navigational bronchoscopy: Initial experience with a novel adjunct. Respirology. 2020;25(2):206–213. doi:10.1111/resp.13609.
- Pritchett MA. Prospective Analysis of a Novel Endobronchial Augmented Fluoroscopic Navigation System for Diagnosis of Peripheral Pulmonary Lesions. J Bronchology Interv Pulmonol. 2021;28(2):107–15. doi:10.1097/LBR.0000000000000700.
- Chaddha U, Kovacs SP, Manley C, et al. Robot-assisted bronchoscopy for pulmonary lesion diagnosis: results from the initial multicenter experience. BMC Pulm Med. 2019;19(1):243 doi:10.1186/s12890-019-1010-8.
- Chen AC, Pastis NJ, JrMahajan AK, et al. Robotic Bronchoscopy for Peripheral Pulmonary Lesions: A Multicenter Pilot and Feasibility Study (BENEFIT). Chest. 2020;S0012-3692(20):34233–34231.
- Yarmus L, Akulian J, Wahidi M, et al. A Prospective Randomized Comparative Study of Three Guided Bronchoscopic Approaches for Investigating Peripheral Pulmonary Nodules: The PRECISION-1 Study. Chest. 2020;157(3):694–701. doi:10.1016/j.chest.2019.10.016.
- Martinez-Zayas G, Almeida FA, Simoff MJ, et al. A Prediction Model to Help with Oncologic Mediastinal Evaluation for Radiation: HOMER. Am J Respir Crit Care Med. 2020;201(2):212–223. doi:10.1164/rccm.201904-0831OC.
- Zúñiga PVS, Martinez-Zayas G, Molina S, Grosu HB, Arain MH, Ost DE. Is Biopsy of Contralateral Hilar N3 Lymph Nodes that are PET-CT Negative Necessary When Performing EBUS Staging? Chest. 2020; S0012-3692(20)34936-9. doi:10.1016/j.chest.2020.10.041.
- Criner GJ, Delage A, Voelker K, et al. Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial. Am J Respir Crit Care Med. 2019;200(11):1354–1362. doi:10.1164/rccm.201902-0383OC.
- Dipper A, Jones HE, Bhatnagar R, Preston NJ, Maskell N, Clive AO. Interventions for the management of malignant pleural effusions: a network meta-analysis. Cochrane Database Syst Rev. 2020;4(4):CD010529 doi:10.1002/14651858.CD010529.pub3.
- Bhatnagar R, Piotrowska HEG, Laskawiec-Szkonter M, et al. Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial. JAMA. 2020;323(1):60–69. doi:10.1001/jama.2019.19997.
- Wilshire C, Chang S, Gilbert CR, et al. Association between Tunneled Pleural Catheter Use and Infection in Patients Immunosuppressed from Antineoplastic Therapy: A Multicenter Study. Ann Am Thorac Soc. 2021;18(4):606–12. doi:10.1513/AnnalsATS.202007-886OC.
- Miller RJ, Chrissian AA, Lee YCG, et al. AABIP Evidence-informed Guidelines and Expert Panel Report for the Management of Indwelling Pleural Catheters. J Bronchology Interv Pulmonol. 2020;27(4):229–245. doi:10.1097/LBR.0000000000000707.
- Gilbert CR, Wahidi MM, Light RW, Interventional Pulmonary Outcomes Group, et al. Management of Indwelling Tunneled Pleural Catheters: A Modified Delphi Consensus Statement. Chest. 2020;158(5):2221–2228. doi:10.1016/j.chest.2020.05.594.
- Kheir F, Thakore S, Mehta H, et al. Intrapleural Fibrinolytic Therapy versus Early Medical Thoracoscopy for Treatment of Pleural Infection. Randomized Controlled Clinical Trial. Ann Am Thorac Soc. 2020;17(8):958–964. doi:10.1513/AnnalsATS.202001-076OC.
- Brown SGA, Ball EL, Perrin K, PSP Investigators, et al. Conservative versus Interventional Treatment for Spontaneous Pneumothorax. N Engl J Med. 2020;382(5):405–415. doi:10.1056/NEJMoa1910775.
- Hallifax RJ, McKeown E, Sivakumar P, et al. Ambulatory management of primary spontaneous pneumothorax: an open-label randomised controlled trial. Lancet. 2020;396(10243):39–49. doi:10.1016/S0140-6736(20)31043-6.
- MacDuff A, Arnold A, Harvey J, on behalf of the BTS Pleural Disease Guideline Group. BTS Pleural Disease Guideline Group. Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(Suppl 2):ii18–31. doi:10.1136/thx.2010.136986.